Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It also is developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It is a patented extracorporeal treatment that is applicable to many hard-to-cure blood-borne and neurologic diseases, including Covid-19, other viruses and cancer. The Company’s wholly owned subsidiary is Alaric Corporation.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Annual Dividend Rate
Price/Cash Flow (TTM)